PREPRINT (not peer reviewed)

Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: medRxiv
Date: 2026-07-13
Source: medRxiv
DOI: 10.64898/2026.07.11.26357570
PubMed: Unavailable

Authors

Zarrabi A. J.; Mletzko T.; Grant G.; Peacock C.; Palitsky R. J.; McPherson T.; Shub I.; Eisenacher S.; Maples-Keller J. L.; Kaplan D.; Rothbaum B. O.; Rab F.; Dalal N.; Curseen K. A.; Raison C.; Dunlop B. W.

Watch author

Derived topics and classifications

psilocybin End-of-Life Distress Chronic Pain Spirituality Cancer Patients Healthcare Workers Safety Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-07 Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counselingTherapeutic Advances in Drug Safety · 2026-02-28 Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert Opinion on Drug Safety · 2022-04-26 Opinion Mining of Erowid’s Experience Reports on LSD and Psilocybin-Containing MushroomsDrug Safety · 2025-03-03